William  Banyai net worth and biography

William Banyai Biography and Net Worth

Insider of Twist Bioscience
Bill is a seasoned entrepreneur and silicon engineering expert. He has been a founder or first employee at four different start-ups and advises early stage startups. As VP of hardware engineering at Complete Genomics, he built their sequencing technology and delivered three generations of human genome chips and sequencers. Bill has twice been awarded multi-million dollar DARPA grants for the development of innovative technologies based on silicon micro machining. Bill’s career spans research, product development, and semiconductor device processing. He holds a PhD in Optical Sciences from the University of Arizona, an MS in Electrical Science from University of Michigan, and served as Staff Physicist at Lawrence Livermore National Laboratory.

What is William Banyai's net worth?

The estimated net worth of William Banyai is at least $8.65 million as of October 25th, 2022. Dr. Banyai owns 255,581 shares of Twist Bioscience stock worth more than $8,646,305 as of March 18th. This net worth evaluation does not reflect any other assets that Dr. Banyai may own. Additionally, Dr. Banyai receives a salary of $711,340.00 as Insider at Twist Bioscience. Learn More about William Banyai's net worth.

How old is William Banyai?

Dr. Banyai is currently 69 years old. There are 6 older executives and no younger executives at Twist Bioscience. Learn More on William Banyai's age.

What is William Banyai's salary?

As the Insider of Twist Bioscience Co., Dr. Banyai earns $711,340.00 per year. There are 2 executives that earn more than Dr. Banyai. The highest earning executive at Twist Bioscience is Dr. Emily Marine Leproust Ph.D., Co-Founder, Chairman & CEO, who commands a salary of $1,370,000.00 per year. Learn More on William Banyai's salary.

How do I contact William Banyai?

The corporate mailing address for Dr. Banyai and other Twist Bioscience executives is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. Twist Bioscience can also be reached via phone at (800) 719-0671 and via email at [email protected]. Learn More on William Banyai's contact information.

Has William Banyai been buying or selling shares of Twist Bioscience?

William Banyai has not been actively trading shares of Twist Bioscience during the past quarter. Most recently, William Banyai sold 379 shares of the business's stock in a transaction on Tuesday, October 25th. The shares were sold at an average price of $29.55, for a transaction totalling $11,199.45. Following the completion of the sale, the insider now directly owns 255,581 shares of the company's stock, valued at $7,552,418.55. Learn More on William Banyai's trading history.

Who are Twist Bioscience's active insiders?

Twist Bioscience's insider roster includes William Banyai (Insider), Robert Chess (Director), Keith Crandell (Director), Mark Daniels (Insider), Patrick Finn (Insider), Paula Green (SVP), Jan Johannessen (Director), Emily Leproust (CEO), James Thorburn (CFO), and Patrick Weiss (COO). Learn More on Twist Bioscience's active insiders.

Are insiders buying or selling shares of Twist Bioscience?

In the last year, Twist Bioscience insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $132,000.00. In the last year, insiders at the sold shares 6 times. They sold a total of 6,743 shares worth more than $242,057.80. The most recent insider tranaction occured on March, 14th when insider Dennis Cho sold 93 shares worth more than $3,217.80. Insiders at Twist Bioscience own 3.9% of the company. Learn More about insider trades at Twist Bioscience.

Information on this page was last updated on 3/14/2024.

William Banyai Insider Trading History at Twist Bioscience

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2022Sell379$29.55$11,199.45255,581View SEC Filing Icon  
10/3/2022Sell318$36.14$11,492.52256,161View SEC Filing Icon  
8/22/2022Sell1,275$41.94$53,473.50256,779View SEC Filing Icon  
7/25/2022Sell378$43.19$16,325.82258,729View SEC Filing Icon  
7/5/2022Sell318$36.79$11,699.22259,308View SEC Filing Icon  
5/23/2022Sell1,275$37.04$47,226.00259,926View SEC Filing Icon  
4/25/2022Sell378$33.98$12,844.44261,876View SEC Filing Icon  
2/22/2022Sell1,280$52.66$67,404.80View SEC Filing Icon  
1/25/2022Sell348$54.73$19,046.04View SEC Filing Icon  
1/21/2022Sell245$53.36$13,073.20View SEC Filing Icon  
12/15/2021Sell25,000$85.20$2,130,000.00View SEC Filing Icon  
11/22/2021Sell19,983$101.83$2,034,868.89View SEC Filing Icon  
10/25/2021Sell19,791$118.14$2,338,108.74View SEC Filing Icon  
9/20/2021Sell20,000$113.91$2,278,200.00View SEC Filing Icon  
8/23/2021Sell20,054$105.51$2,115,897.54View SEC Filing Icon  
7/26/2021Sell19,791$115.25$2,280,912.75View SEC Filing Icon  
6/21/2021Sell20,000$114.68$2,293,600.00379,389View SEC Filing Icon  
5/21/2021Sell20,275$96.06$1,947,616.50400,064View SEC Filing Icon  
4/26/2021Sell19,878$137.40$2,731,237.20420,617View SEC Filing Icon  
3/22/2021Sell20,000$132.61$2,652,200.00439,587View SEC Filing Icon  
12/15/2020Sell20,000$132.66$2,653,200.00495,230View SEC Filing Icon  
11/30/2020Sell2,790$113.65$317,083.50496,440View SEC Filing Icon  
7/15/2020Sell11,000$55.61$611,710.00513,892View SEC Filing Icon  
7/8/2020Sell25,000$53.15$1,328,750.00539,635View SEC Filing Icon  
6/15/2020Sell11,000$38.15$419,650.00560,355View SEC Filing Icon  
6/1/2020Sell20,113$40.01$804,721.13562,592View SEC Filing Icon  
5/20/2020Sell22,000$39.66$872,520.00592,051View SEC Filing Icon  
11/18/2019Sell22,000$22.53$495,660.00
10/16/2019Sell22,000$24.14$531,080.00
9/17/2019Sell22,000$29.86$656,920.00
8/27/2019Sell22,000$27.92$614,240.00View SEC Filing Icon  
See Full Table

William Banyai Buying and Selling Activity at Twist Bioscience

This chart shows William Banyai's buying and selling at Twist Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Twist Bioscience Company Overview

Twist Bioscience logo
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $33.83
Low: $32.87
High: $34.52

50 Day Range

MA: $36.65
Low: $32.28
High: $41.50

2 Week Range

Now: $33.83
Low: $11.46
High: $43.21

Volume

634,175 shs

Average Volume

995,473 shs

Market Capitalization

$1.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64